Collegium Pharmaceutical (COLL) Insider Trading & Ownership $26.87 +0.08 (+0.30%) Closing price 04:00 PM EasternExtended Trading$26.87 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Collegium Pharmaceutical (NASDAQ:COLL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.51%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$7.87 M Get COLL Insider Trade Alerts Want to know when executives and insiders are buying or selling Collegium Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COLL Insider Buying and Selling by Quarter Collegium Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2025Colleen TupperCFOSell977$30.00$29,310.00 3/14/2025Scott DreyerEVPSell2,255$30.00$67,650.00 3/11/2025Colleen TupperCFOSell10,445$30.01$313,454.45 3/6/2025Colleen TupperCFOSell1,949$30.00$58,470.00 3/6/2025Shirley R KuhlmannEVPSell26,067$28.50$742,909.50 3/4/2025Shirley R KuhlmannEVPSell40,000$28.08$1,123,200.00 1/10/2025Shirley R KuhlmannEVPSell27,500$33.04$908,600.00 9/13/2024Thomas B SmithEVPSell9,593$36.62$351,295.66 9/5/2024Shirley R KuhlmannEVPSell19,248$38.30$737,198.40 5/28/2024Colleen TupperCFOSell19,710$34.21$674,279.10 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/24/2024Scott DreyerEVPSell56,807$33.98$1,930,301.86 5/14/2024Garen G BohlinDirectorSell28,985$32.30$936,215.50 (Data available from 1/1/2013 forward) COLL Insider Trading Activity - Frequently Asked Questions Who is on Collegium Pharmaceutical's Insider Roster? The list of insiders at Collegium Pharmaceutical includes Colleen Tupper, Garen G Bohlin, Joseph Ciaffoni, Michael Thomas Heffernan, Scott Dreyer, Shirley R Kuhlmann, and Thomas B Smith. Learn more on insiders at COLL. What percentage of Collegium Pharmaceutical stock is owned by insiders? 2.51% of Collegium Pharmaceutical stock is owned by insiders. Learn more on COLL's insider holdings. Which Collegium Pharmaceutical insiders have been selling company stock? The following insiders have sold COLL shares in the last 24 months: Colleen Tupper ($1,075,513.55), Garen G Bohlin ($936,215.50), Joseph Ciaffoni ($1,943,914.52), Scott Dreyer ($2,758,468.66), Shirley R Kuhlmann ($4,562,488.38), and Thomas B Smith ($351,295.66). How much insider selling is happening at Collegium Pharmaceutical? Insiders have sold a total of 392,096 Collegium Pharmaceutical shares in the last 24 months for a total of $11,627,896.27 sold. Collegium Pharmaceutical Key ExecutivesMr. Michael Thomas Heffernan B.S. Pharm (Age 60)R.Ph., Co-Founder & Chairman Compensation: $110kMr. Joseph J. Ciaffoni (Age 52)President, CEO & Director Compensation: $1.69MMs. Colleen Tupper (Age 48)Executive VP & CFO Compensation: $848.29k3 recent tradesMs. Shirley R. Kuhlmann (Age 40)Executive VP, General Counsel, Chief Administrative Officer & Secretary Compensation: $842.9k3 recent tradesMr. Scott Dreyer (Age 52)Executive VP & Chief Commercial Officer Compensation: $746.58k1 recent tradesDr. Thomas B. Smith FAAFP (Age 63)M.D., Executive VP & Chief Medical Officer Compensation: $692.91kDr. Christopher Shayne James M.D.Vice President of Investor RelationsMr. Bart J. DunnExecutive Vice President of Strategy & Corporate DevelopmentMr. Scott SudduthHead of Technical Operations More Insider Trading Tools from MarketBeat Related Companies RNA Insider Buying ACLX Insider Buying RARE Insider Buying ZLAB Insider Buying AKRO Insider Buying MRUS Insider Buying SRRK Insider Buying PTGX Insider Buying CRNX Insider Buying SWTX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:COLL) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
